Neurodegenerative Diseases
-
autophagy, genetics, lysosomes, mitochondria, mitophagy, Neurodegenerative Diseases, neuroscience, Parkin, parkinson’s disease, PINK1, ubiquitinPINK1 and Parkin Link Parkinson’s Disease to Failed Mitochondrial Cleanup
A 2026 review ties the Parkinson’s disease genes PINK1 and parkin to…
-
autophagy, genetics, lysosomes, neurodegeneration, Neurodegenerative Diseases, neuroscience, parkinson’s disease, potassium channel, proton channel, TMEM175TMEM175 Proton Channel Finding Clarifies Parkinson’s Lysosome Risk
A 2026 PNAS study found that TMEM175 behaves as a pH-sensitive lysosomal…
-
action units, Brain, cognition, dementia screening, digital biomarkers, facial expression, mild cognitive impairment, MoCA, Neurodegenerative Diseases, neuroscience, older adults, OpenFaceFacial Markers Differed in 31 Older Adults With MCI-Level MoCA Scores
A 2026 medRxiv preprint found that older adults with mild-cognitive-impairment-level MoCA-J scores…
-
autonomic dysfunction, Brain, brain-heart coupling, cognitive screening, ECG, eeg, freezing of gait, heart rate variability, MMSE, Neurodegenerative Diseases, neuroscience, parkinson’s diseaseParkinson’s Brain-Heart Coupling Signals MMSE and Freezing of Gait
A 2026 EEG-ECG preprint reported that beta efficiency-sympathetic coupling differed across healthy…
-
caregiver burden, Chinese American caregivers, cultural adaptation, dementia caregivers, dementia stigma, family counseling, KakaoTalk, Korean American caregivers, Neurodegenerative Diseases, NYUCI-ES, Psychiatry, Psychology, therapy, TIDieR, WeChatDementia Caregiver Intervention Needed 24 Cultural Adaptations
A 2026 descriptive study documented 24 major cultural adaptations to the New…
-
A4 study, ADNI, Alzheimer’s disease, amyloid PET, blood biomarker, Brain, calibration, cognition, machine learning, negative predictive value, Neurodegenerative Diseases, p-tau217, plasma biomarkersAlzheimer’s Blood Biomarker Models Lose Rule-Out Power Across Cohorts
A 2026 ADNI/A4 validation study found that Alzheimer’s plasma-biomarker machine-learning models still…
-
A-beta 42/40, Alzheimer’s disease, amyloid PET, blood biomarkers, Brain, Clarity AD, cognition, GFAP, lecanemab, maintenance dosing, Neurodegenerative Diseases, p-tau181, PK/PD modelingLecanemab Blood Biomarkers Rebound Faster Than Amyloid PET After Stopping
Lecanemab blood biomarkers may rebound much faster than amyloid PET after treatment…


